RVTY Stock: Price, Earnings History and SEC Filings
Revvity, Inc. (RVTY) last traded at $157.00, down 5.30% on the latest session and up 2.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.41 against an analyst estimate of $1.23, a beat of 14.6%.
$157.00 -5.30%
1 month+2.69%
52-week high$169.06
52-week low$81.22
Volume3.18M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
RVTY earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $1.41 | $1.23 | +14.63% |
| Mar 2026 | May 5, 2026 | $1.06 | $1.02 | +3.92% |
| Dec 2025 | Feb 2, 2026 | $1.70 | $1.59 | +6.92% |
| Sep 2025 | Oct 27, 2025 | $1.18 | $1.14 | +3.51% |
RVTY beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for RVTY
SEC filing data is not available right now. You can search for RVTY on SEC EDGAR.
RVTY news
- Revvity Board Declares Quarterly DividendOct 30, 2026 · finance.yahoo.com
- Revvity (RVTY) Stock May Be Trading At A Premium On Its AI Workflow LaunchOct 30, 2026 · finance.yahoo.com
- Global Genetic Counseling Services Market Report 2026 | Capitalize on AI and Telehealth as Market Hits $4.67 Billion by 2030: Labcorp, Quest Diagnostics, Natera, GeneDxOct 30, 2026 · finance.yahoo.com
- Revvity Gears Up to Post Q3 Earnings: What's in Store for the Stock?Oct 30, 2026 · finance.yahoo.com
- Edwards' Q3 Earnings on the Horizon: What's in the Cards?Oct 30, 2026 · finance.yahoo.com
- 4 Medical Stocks With a Healthy Shot at Q3 Earnings BeatsOct 30, 2026 · finance.yahoo.com
- GRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive GrowthOct 29, 2026 · finance.yahoo.com
- 2 S&P 500 stocks with competitive advantages and 1 we turn downOct 29, 2026 · finance.yahoo.com
About Revvity, Inc.
Revvity, Inc. (RVTY) is a US-listed public company on NYSE.